AEKYUNG INDUSTRIAL Participates in U.S. Cosmoprof… “K-Beauty’s Popularity Confirmed on the Ground”
Makeup, Hair, and Body Care Products on Display at Las Vegas Trade Show
Positive Response to Color Cosmetics… Consultations with Buyers from North and South America Continue
"Accelerating the Expansion of Global Distribution Networks and Penetration of Overseas Markets"
[Edaily Reporter Han Jeon-jin ] Aekyung Industries (AEKYUNG INDUSTRIAL(018250)) announced on the 15th that it operated a dedicated experience booth at “Cosmoprof Las Vegas 2026” to showcase a wide range of products, from makeup to hair and body care.
AEKYUNG INDUSTRIAL showcasing its products at “Cosmoprof Las Vegas 2026.” (Photo courtesy of AEKYUNG INDUSTRIAL)The booth featured a space where visitors could try outthe productsfirsthand, as well as interactive promotions, and also held an event where customers who tried the main products received free samples.
Hong Young-ki, Head of the Makeup W.W. Sales Team at AEKYUNG INDUSTRIAL, said, “We were able to witness firsthand the intense interest in K-Beauty at the event,” adding, “In particular, the response from buyers and consumers to our color cosmetics exceeded our expectations.”
Jeong Chang-il, Head of the Daily Care W.W. Sales Team, said, “We continued substantive discussions on distribution partnerships with local buyers, focusing on hair and body care products,” adding, “Taking this exhibition as an opportunity, we will accelerate our expansion into the North and South American markets and leap forward to become a global total beauty company.”Customers gather at the booth to listen to product explanations. (Photo courtesy of AEKYUNG INDUSTRIAL) (Photo courtesy of AEKYUNG INDUSTRIAL)
A virtual creator that doesn’t require a human actor has emerged. There is no pre-written script, nor is there an operator manipulating it in real time. Artificial intelligence (AI) hosts the broadcas…
“When you examine the kidneys of mice with polycystic kidney disease, you can see large cysts. However, after administering Udenafil, a reduction in the size of these cysts was visible even to the nak…
(Graphic: Generative AI)
During the first week of August (August 3–7), SK BIOPHARMACEUTICALS posted its best-ever quarterly earnings, driven by the growth of its new epilepsy drug “cenobamate.” Ad…
